Leukemia and lymphoma: A cost of doing business for adaptive immunity

Genes and Development

Volumn 20, Issue 12, 2006, Pages 1539-1544

  Schlissel, Mark S ^a   Kaffer, Chris R ^a   Curry, John D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINASE; SIGNAL PEPTIDE; TRANSPOSASE;

B CELL LEUKEMIA; CANCER; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA TRANSPOSITION; GENE CONTROL; GENOMIC INSTABILITY; HUMAN; IMMUNITY; LEUKEMIA; LYMPHOCYTE; LYMPHOMA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR GENE; REVIEW; SOMATIC HYPERMUTATION; T CELL LEUKEMIA;

ANIMALS; GENOMIC INSTABILITY; IMMUNITY; LEUKEMIA; LYMPHOMA; MICE; RECEPTORS, ANTIGEN; TRANSLOCATION, GENETIC; VDJ RECOMBINASES;

EID: 33745121244     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1446506     Document Type: Review

References (37)

1. Agrawal, A., Eastman, Q.M., and Schatz, D.G. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394: 744-751.
2. Aplan, P.D., Lombardi, D.P., Ginsberg, A.M., Cossman, J., Bertness, V.L., and Kirsch, I.R. 1990. Disruption of the human SCL locus by 'illegitimate' V-(D)-J recombinase activity. Science 250: 1426-1429.
3. Bassing, C.H., Suh, H., Ferguson, D.O., Chua, K.F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., and Alt, F.W. 2003. Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370.
4. Chatterji, M., Tsai, C.L., and Schatz, D.G. 2006. Mobilization of RAG-generated signal ends by transposition and insertion in vivo. Mol. Cell. Biol. 26: 1558-1568.
5. Clatworthy, A.E., Valencia, M.A., Haber, J.E., and Oettinger, M.A. 2003. V(D)J recombination and RAG-mediated transposition in yeast. Mol. Cell 12: 489-499.
6. Curry, J.D., Geier, J.K., and Schlissel, M.S. 2005. Single-strand recombination signal sequence nicks in vivo: Evidence for a capture model of synapsis. Nat. Immunol. 6: 1272-1279.
7. Finette, B.A., Poseno, T., and Albertini, R.J. 1996. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res. 56: 1405-1412.
8. Finette, B.A., Kendall, H., and Vacek, P.M. 2002. Mutational spectral analysis at the HPRT locus in healthy children. Mutat. Res. 505: 27-41.
9. Gellert, M. 2002. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71: 101-132.
10. Hiom, K., Melek, M., and Gellert, M. 1998. DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations. Cell 94: 463-470.
11. Honjo, T., Nagaoka, H., Shinkura, R., and Muramatsu, M. 2005. AID to overcome the limitations of genomic information. Nat. Immunol. 6: 655-661.
12. Jones, J.M. and Gellert, M. 2004. The taming of a transposon: V(D)J recombination and the immune system. Immunol. Rev. 200: 233-248.
13. Jung, D. and Alt, F.W. 2004. Unraveling V(D)J recombination; insights into gene regulation. Cell 116: 299-311.
14. Kirsch, I.R. and Lista, F. 1997. Lymphocyte-specific genomic instability and risk of lymphoid malignancy. Semin. Immunol. 9: 207-215.
15. Kuppers, R. and Dalla-Favera, R. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20: 5580-5594.
16. Lee, G.S., Neiditch, M.B., Salus, S.S., and Roth, D.B. 2004. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 117: 171-184.
17. Lewis, S.M. and Wu, G.E. 1997. The origins of V(D)J recombination. Cell 88: 159-162.
18. Li, Z., Woo, C.J., Iglesias-Ussel, M.D., Ronai, D., and Scharff, M.D. 2004. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes & Dev. 18: 1-11.
19. Maizels, N. 2005. Immunoglobulin gene diversification. Annu. Rev. Genet. 39: 23-46.
20. Melek, M. and Gellert, M. 2000. RAG1/2-mediated resolution of transposition intermediates: Two pathways and possible consequences. Cell 101: 625-633.
21. Messier, T.L., O'Neill, J.P., Hou, S.M., Nicklas, J.A., and Finette, B.A. 2003. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. EMBO J. 22: 1381-1388.
22. Mills, K.D., Ferguson, D.O., and Alt, F.W. 2003. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194: 77-95.
23. Negrini, M., Felix, C.A., Martin, C., Lange, B.J., Nakamura, T., Canaani, E., and Croce, C.M. 1993. Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia. Cancer Res. 53: 4489-4492.
24. Neiditch, M.B., Lee, G.S., Huye, L.E., Brandt, V.L., and Roth, D.B. 2002. The V(D)J recombinase efficiently cleaves and transposes signal joints. Mol. Cell 9: 871-878.
25. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, R., and Dalla-Favera, R. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412: 341-346.
26. Raghavan, S.C., Kirsch, I.R., and Lieber, M.R. 2001. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J. Biol. Chem. 276: 29126-29133.
27. Raghavan, S.C., Swanson, P.C., Wu, X., Hsieh, C.L., and Lieber, M.R. 2004. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428: 88-93.
28. Ramiro, A.R., Jankovic, M., Callen, E., Difilippantonio, S., Chen, H.T., McBride, K.M., Eisenreich, T.R., Chen, J., Dickins, R.A., Lowe, S.W., et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440: 105-109.
29. Reddy, Y.V.R., Perkins, E.J., and Ramsden, D.A. 2006. Genomic instability due to V(D)J recombination-associated transposition. Genes & Dev. (this issue).
30. Sen, R. and Oltz, E. 2006. Genetic and epigenetic regulation of IgH gene assembly. Curr. Opin. Immunol. 18: 237-242.
31. Spilianakis, C.G., Lalioti, M.D., Town, T., Lee, G.R., and Flavell, R.A. 2005. Interchromosomal associations between alternatively expressed loci. Nature 435: 637-645.
32. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., and Leder, P. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. 79: 7837-7841.
33. Tsai, C.L. and Schatz, D.G. 2003. Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2. EMBO J. 22: 1922-1930.
34. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., and Croce, C.M. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393.
35. Tycko, B., Reynolds, T.C., Smith, S.D., and Sklar, J. 1989. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia. J. Exp. Med. 169: 369-377.
36. Wiemels, J.L., Leonard, B.C., Wang, Y., Segal, M.R., Hunger, S.P., Smith, M.T., Crouse, V., Ma, X., Buffler, P.A., and Pine, S.R. 2002. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. 99: 15101-15106.
37. Zhu, C., Mills, K.D., Ferguson, D.O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C.C., and Alt, F.W. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109: 811-821.